Harrow (HROW) Interest Expenses (2010 - 2026)
Harrow (HROW) recorded quarterly Interest Expenses of $5.5 million in Q1 2026, up 6.0% quarter-over-quarter from $5.2 million in Q4 2025, and down 16.05% on a YoY basis from $6.5 million in Q1 2025.
Harrow (HROW) Interest Expenses (2010 - 2026) Analysis & Trends
Harrow's Interest Expenses history runs 14 years deep, the most recent figure standing at $5.5 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 16.05% year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $18.0 million (down 24.75% YoY), while the FY2025 annual figure was $24.2 million, up 6.12% from the prior year.
- Interest Expenses was $5.5 million for Q1 2026 at Harrow, up from $5.2 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $6.5 million in Q1 2025 to a low of $907000.0 in Q3 2025.
- Historically, Interest Expenses has averaged $4.5 million across 5 years, with a median of $5.4 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses surged 547.48% in 2022, then slumped 83.58% in 2025.
- A 5-year view of Interest Expenses shows it stood at $1.9 million in 2022, then surged by 175.78% to $5.1 million in 2023, then grew by 24.41% to $6.4 million in 2024, then retreated by 18.65% to $5.2 million in 2025, then grew by 6.0% to $5.5 million in 2026.
- The last three Interest Expenses figures came in at $5.5 million (Q1 2026), $5.2 million (Q4 2025), and $907000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4.86 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | 5.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.50 Mn |
| Mar 31, 2026 | 5.50 Mn |
| Dec 31, 2025 | 5.19 Mn |
| Dec 31, 2025 | 5.19 Mn |
| Sep 30, 2025 | 907,000.00 |
| Sep 30, 2025 | 907,000.00 |
| Jun 30, 2025 | 6.41 Mn |
| Jun 30, 2025 | 6.41 Mn |
| Mar 31, 2025 | 6.55 Mn |
| Mar 31, 2025 | 6.55 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 5.53 Mn |
| Sep 30, 2024 | 5.53 Mn |
| Jun 30, 2024 | 5.47 Mn |
| Jun 30, 2024 | 5.47 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Dec 31, 2023 | 5.12 Mn |
| Dec 31, 2023 | 5.12 Mn |